LEADER 02122nam 2200349 450 001 9910774867503321 005 20230223214355.0 035 $a(CKB)2560000000291798 035 $a(NjHacI)992560000000291798 035 $a(EXLCZ)992560000000291798 100 $a20230223d2013 uy 0 101 0 $aita 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAgricoltura paesaggistica $eVisioni, metodi, esperienze /$fDaniela Poli 210 1$aFirenze :$cFirenze University Press,$d2013. 215 $a1 online resource (xxi, 298 pages) $cillustrations 311 $a88-6655-437-5 330 $a"L'agricoltura e? la prima delle arti" was born from a project, from the conscious modification of a context, using knowledge which had been shared and accumulated over time. Contemporary agriculture, the daughter of the 'green revolution', of Fordism and its crisis, turned its back on the knowledge that agriculture was able to produce not only food, but also environmental protection and aesthetic quality. The texts collected in this volume are intended to encourage reflections and practices in the various areas of territory and landscape planning and design - on the university, political, technical, professional and administrative levels - which can lead the world of agriculture to regain a central role in outlining new relationships between inhabitants and territory. In these texts, the agricultural landscape represents an opportunity to produce a context where it is pleasant to live, with an approach far from the aesthetical drift of a 'picturesque' and imaginary misunderstanding; an approach which is however careful towards a contextual aesthetic, arising within and from the rural world. 517 $aAgricoltura paesaggistica 606 $aLandscape assessment 615 0$aLandscape assessment. 676 $a712 700 $aPoli$b Daniela$0326199 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910774867503321 996 $aAgricoltura paesaggistica$93665313 997 $aUNINA LEADER 03048nam 22005175 450 001 9910506387603321 005 20251113193513.0 010 $a3-030-79790-2 024 7 $a10.1007/978-3-030-79790-4 035 $a(CKB)5340000000068524 035 $a(MiAaPQ)EBC6789935 035 $a(Au-PeEL)EBL6789935 035 $a(OCoLC)1280461997 035 $a(PPN)258297719 035 $a(DE-He213)978-3-030-79790-4 035 $a(EXLCZ)995340000000068524 100 $a20211022d2021 u| 0 101 0 $aeng 135 $aur|z||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNew Rapid-acting Antidepressants /$fedited by Kenji Hashimoto, Mario Manto 205 $a1st ed. 2021. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021. 215 $a1 online resource (152 pages) 225 1 $aContemporary Clinical Neuroscience,$x2627-5341 300 $aIncludes index. 311 08$a3-030-79789-9 327 $a(R)-ketamine: A new rapid-acting antidepressant -- (2R,6R)-hydroxynorketamine, a metabolite of ketamine: the antidepressant actions and the mechanisms -- Predictable biomarkers for rapid-acting antidepressant response to ketamine -- Nitrous Oxide: an old compound with emerging psychotropic properties -- Novel AMPA receptor potentiators TAK-137 and TAK-653 as potential rapid-acting antidepressants -- AMPA receptor potentiators as potential rapid-acting antidepressants -- mGlu2/3 receptor antagonists as rapid-acting antidepressants -- Antidepressant effects of the muscarinic receptor antagonist scopolamine: Clinical and preclinical review. 330 $aThis book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area. In this volume, a variety of novel pharmaceutical treatments are examined. This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments. Discusses new candidate for rapid-acting antidepressants Provides information for those who work in the field of CNS drugs Ideal for pharmacologists, psychiatrists, and those who want to learnabout CNS drugs at the graduate level. 410 0$aContemporary Clinical Neuroscience,$x2627-5341 606 $aNeurosciences 606 $aNeuroscience 615 0$aNeurosciences. 615 14$aNeuroscience. 676 $a616.8527061 702 $aHashimoto$b Kenji 702 $aManto$b Mario 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910506387603321 996 $aNew rapid-acting Antidepressants$92900064 997 $aUNINA